Lumaegis, Inc. has successfully closed a $200,000 pre-seed funding round, led by one of their global strategic partners. The funds will be used to build the next set of production units and conduct FDA testing. The RadBox, a patent-protected sterilization device, has received FDA De Novo classification

Lumaegis is headquartered in Austin, TX and is a member of University of Texas’ Austin Technology Incubator. Its mission is to support global health security and to reduce the environmental impact of sterilization processes globally. The founders are seasoned serial entrepreneurs with a proven track record of leveraging technology to address sustainability challenges.




https://lumaegis.com/

Biotechnology

Lumaegis secures $200,000 in pre-seed funding to accelerate FDA certification for its innovative sterilization technology.

Description

Company Information

Related People

Funding Insights

Lumaegis secures $200,000 in pre-seed funding to accelerate FDA certification for its innovative sterilization technology.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information